Abellan R, Ventura R, Pichini S, Di Giovannandrea R, Bellver M, Olive R, Pacifici R, Pascual J A, Zuccaro P, Segura J
Pharmacology Research Unit, Institut Municipal d'Investigació Mèdica, Barcelona, Spain.
Int J Sports Med. 2006 Dec;27(12):976-83. doi: 10.1055/s-2006-923864. Epub 2006 Apr 11.
Serum insulin-like growth factor-I (IGF-I) and procollagen type III peptide (P-III-P) have been proposed as indirect biomarkers of rhGH misuse in sports. The purpose of the present study was to investigate concentrations of these biomarkers in athletes at different levels of physical fitness and endurance exercise. Serum total IGF-I and P-III-P were measured in 96 elite athletes of various sports along the training season; in 21 recreational athletes at baseline non-exercising conditions and in another 129 recreational athletes before and after long-distance races (10 and 21 km). No differences were evidenced for IGF-I concentrations, but statistically higher values of serum P-III-P were found in elite athletes compared to recreational ones. Among elite athletes, the specific sport did not affect serum IGF-I. However, P-III-P was statistically higher in the sport performed by the youngest athletes (rhythmic gymnastics), even after correction of the logarithm of the concentration by the reciprocal of age. Over the training season, the within-athlete variabilities of IGF-I and P-III-P in elite athletes were low (22.8 % and 21.7 %, respectively). Recreational athletes taking part in a 21 km competition race showed a significant increase in serum values of IGF-I and P-III-P immediately after the event. Exercise workload and age had a significant effect on serum concentration of P-III-P, while age alone affected IGF-I serum concentrations. Therefore, athlete's reference concentration ranges for doping detection should include subjects from as many different ages and sports as possible.
血清胰岛素样生长因子-I(IGF-I)和III型前胶原肽(P-III-P)已被提议作为体育运动中生长激素滥用的间接生物标志物。本研究的目的是调查这些生物标志物在不同体能和耐力运动水平运动员中的浓度。在96名不同项目的精英运动员的整个训练季节中测量血清总IGF-I和P-III-P;在21名休闲运动员处于非运动基线状态时以及另外129名休闲运动员参加长跑比赛(10公里和21公里)前后进行测量。IGF-I浓度未发现差异,但与休闲运动员相比,精英运动员的血清P-III-P值在统计学上更高。在精英运动员中,具体运动项目不影响血清IGF-I。然而,即使通过年龄的倒数对浓度的对数进行校正后,在最年轻运动员所从事的运动项目(艺术体操)中,P-III-P在统计学上仍更高。在整个训练季节中,精英运动员体内IGF-I和P-III-P的变异性较低(分别为22.8%和21.7%)。参加21公里比赛的休闲运动员在比赛后血清IGF-I和P-III-P值显著增加。运动负荷和年龄对血清P-III-P浓度有显著影响,而仅年龄影响IGF-I血清浓度。因此,用于兴奋剂检测的运动员参考浓度范围应包括尽可能多不同年龄和运动项目的受试者。